Nasal inoculation with a-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamine

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: onr:"swepub:oai:DiVA.org:umu-71313" > Nasal inoculation w...

1 of 1
Previous record
Next record
To hitlist

Details
MARC

Gruden, Marina A. (author)

Nasal inoculation with a-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamine

Article/chapterEnglish2013

Publisher, publication year, extent ...

Elsevier BV,2013
printrdacarrier

Numbers

LIBRIS-ID:oai:DiVA.org:umu-71313
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-71313URI
https://doi.org/10.1016/j.bbr.2013.01.011DOI

Supplementary language notes

Language:English
Summary in:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:ref swepub-contenttype
Subject category:art swepub-publicationtype

Notes

Animal models of Parkinson's disease (PD) have been widely used to investigate the pathogenesis of this neurodegenerative disorder which is typically associated with the specific and largely disordered protein alpha-synuclein (alpha-syn). In the current study, the nasal vector was used to deliver alpha-syn aggregates to the brain. Both alpha-syn oligomers and its fibrils were firstly characterized using atomic force microscopy and the thioflavin T binding assay. The toxic oligomers alone (0.48 mg/kg) or their 50:50 combination with fibrils (in a total dose of 0.48 mg/kg) were then given intranasally for ten days in mice and PD-mimetic symptoms as well as humoral immunity to these species and dopamine (DA) were evaluated simultaneously. Open-field behavioral deficits indicated by rigidity and reduced locomotor activity were induced by the dual administration of alpha-syn oligomers plus fibrils but not the oligomers by themselves under the 10-day dosing regimen. In contrast, using ELISA, high levels of serum autoantibodies to alpha-syn monomeric, oligomeric and fibrillar conformers as well as DA were observed in both treatment groups reflecting immune system activation and this substantiates previous clinical studies in Parkinson's disease patients. Thus, nasal administration of alpha-syn amyloidogenic species may be a potential experimental PD model which results not only in motor deficits but also incitement of humoral protection to mimic the disease. Such a paradigm may be exploitable in the quest for potential therapeutic strategies and further studies are warranted.

Subject headings and genre

MEDICIN OCH HÄLSOVETENSKAP Medicinsk bioteknologi Medicinsk bioteknologi hsv//swe
MEDICAL AND HEALTH SCIENCES Medical Biotechnology Medical Biotechnology hsv//eng
alpha-Synuclein oligomers
Fibrils
Rigidity
Locomotor activity
Autoantibodies
Dopamine
Rodent

Added entries (persons, corporate bodies, meetings, titles ...)

Davidova, Tatiana V. (author)
Yanamandra, KiranUmeå universitet,Institutionen för medicinsk kemi och biofysik (author)
Kucheryanu, Valery G. (author)
Morozova-Roche, Ludmilla A.Umeå universitet,Institutionen för medicinsk kemi och biofysik(Swepub:umu)lumo0001 (author)
Sherstnev, Vladimir V. (author)
Sewell, Robert D. E. (author)
Umeå universitetInstitutionen för medicinsk kemi och biofysik (creator_code:org_t)

Related titles

In:Behavioural Brain Research: Elsevier BV243, s. 205-2120166-43281872-7549

Internet link

Find in a library

Behavioural Brain Research (Search for host publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Gruden, Marina A ...; Davidova, Tatian ...; Yanamandra, Kira ...; Kucheryanu, Vale ...; Morozova-Roche, ...; Sherstnev, Vladi ...; show more...; Sewell, Robert D ...; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Medical Biotechn ...; and Medical Biotechn ...

Articles in the publication: Behavioural Brai ...

By the university: Umeå University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se